Literature DB >> 14720291

Recent progress of vascular graft engineering in Japan.

Takehisa Matsuda1.   

Abstract

The development of a small-diameter vascular graft has long been awaited. This review covers research activities, achievements and progress on vascular engineering in Japan, which was conducted over the last decade. The article includes recently developed experimental scaffolds, biologically active artificial extracellular matrices (ECMs) or non-fouling synthetic coatings, cell sourcing including the autologous vascular cell type, endothelial progenitor cells and genetically-engineered, temporary endothelial-like cells. The discussions were presented from biomechanical, biomaterial, cellular and tissue aspects. Once the mechano-biological and biologically active extracellular milieus are established in a designed vascular graft, the functional, structural and mechanical tissue morphogenesis and adaptation of implanted vascular grafts may proceed with implantation duration, and the spatio-temporal tissue modulations at cytokine, cellular, ECM levels under physiological stress proceed to regenerate vascular tissue architecture. The ultimate solution to a small-diameter vascular graft should be realized by optimal combinations of these factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720291     DOI: 10.1111/j.1525-1594.2004.07324.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Membrane thickness design of implantable bio-MEMS sensors for the in-situ monitoring of blood flow.

Authors:  C A Steeves; Y L Young; Z Liu; A Bapat; K Bhalerao; A B O Soboyejo; W O Soboyejo
Journal:  J Mater Sci Mater Med       Date:  2007-01       Impact factor: 3.896

2.  Pericyte-based human tissue engineered vascular grafts.

Authors:  Wei He; Alejandro Nieponice; Lorenzo Soletti; Yi Hong; Burhan Gharaibeh; Mihaela Crisan; Arvydas Usas; Bruno Peault; Johnny Huard; William R Wagner; David A Vorp
Journal:  Biomaterials       Date:  2010-08-03       Impact factor: 12.479

3.  Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein involvement: Chinese center experience.

Authors:  Zhi-Bo Xie; Ji-Chun Gu; Yi-Fan Zhang; Lie Yao; Chen Jin; Yong-Jian Jiang; Ji Li; Feng Yang; Cai-Feng Zou; De-Liang Fu
Journal:  Oncotarget       Date:  2017-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.